Metabolic Disturbances Associated with the Use of the Atypical Antipsychotics

被引：0
|
作者：
Thomas, Barbara [1 ]
机构：
[1] Hlth Care Corp St Johns, Waterford Site, St John, NF, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2005年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Weight gain and metabolic disturbances associated with the atypical antipsychotics
    Rivas-Vazquez, RA
    Rey, J
    [J]. PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2002, 33 (03) : 341 - 344
  • [2] Metabolic Effects Associated to Atypical Antipsychotics
    Amboage Paz, M. T.
    Diaz Peromingo, J. A.
    [J]. NORTE DE SALUD MENTAL, 2008, 7 (32): : 37 - 40
  • [3] Features of the metabolic syndrome associated with the use of atypical antipsychotics: Is there a role for adiponectin?
    Almeras, N
    Bouchard, RH
    Demers, MF
    Villeneuve, J
    Roy, MA
    Despres, JP
    [J]. OBESITY RESEARCH, 2004, 12 : A130 - A130
  • [4] Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
    Hasnain, Mehrul
    Fredrickson, Sonja K.
    Vieweg, W. Victor R.
    Pandurangi, Anand K.
    [J]. CURRENT DIABETES REPORTS, 2010, 10 (03) : 209 - 216
  • [5] Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
    Mehrul Hasnain
    Sonja K. Fredrickson
    W. Victor R. Vieweg
    Anand K. Pandurangi
    [J]. Current Diabetes Reports, 2010, 10 : 209 - 216
  • [6] Hyperglycemia associated with the use of atypical antipsychotics
    Lindenmayer, JP
    Nathan, AM
    Smith, RC
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 30 - 38
  • [7] Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics
    Karagianis, JL
    Dunayevich, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 137 - 137
  • [8] Review: metformin is effective at attenuating the metabolic risks associated with use of atypical antipsychotics
    Klein, David J.
    Saldana, Shannon N.
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2011, 14 (02) : 55 - 55
  • [9] Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics
    Alméras, N
    Després, JP
    Villeneuve, J
    Demers, MF
    Roy, MA
    Cadrin, C
    Mottard, JP
    Bouchard, RH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 557 - 564
  • [10] Intervention to improve the rate of metabolic monitoring and prevent the metabolic syndrome associated with the use of atypical antipsychotics
    Poojari, Pooja G. Gopal
    Thunga, Girish P.
    Khan, Sohil
    Shenoy, Sonia
    Pai, Keshava
    Shetty, Sahana
    Acharya, Leelavathi D.
    Bose, Swarnali
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 636 - 636
12345